Pre-Market Earnings Report for November 12, 2025 : TDG, GFS, TME, ONON, ICL, LOAR, HBM, LEGN, ENLT, IHS, ARCO, CRMD

A diverse group of companies is set to report Q3 2025 earnings on November 12, 2025, providing key insights across various sectors. Forecasts include Transdigm Group (TDG) with an anticipated 4.57% year-over-year EPS increase to $9.61, On Holding AG (ONON) projecting a significant 100% EPS surge to $0.20, and CorMedix Inc. (CRMD) expecting an exceptional 1060% EPS growth to $0.48. Many of these firms, such as Tencent Music (TME), also exhibit P/E ratios that imply higher growth potential compared to their respective industry averages, signaling important performance differentials for investors to monitor.

Analysis

A diverse set of companies is scheduled to report Q3 2025 earnings on November 12, 2025, presenting a mixed outlook across various sectors. CorMedix Inc. (CRMD) stands out with a projected 1060.00% year-over-year EPS increase to $0.48, alongside On Holding AG (ONON) forecasting a 100.00% surge to $0.20 and IHS Holding Limited (IHS) expecting a 116.39% rise to $0.10, indicating robust growth trajectories.

Conversely, some firms face headwinds; Legend Biotech Corporation (LEGN) anticipates a negative EPS of $-0.13, despite a percentage increase from a lower base, and missed Q2 2025 consensus by -54.55%. Enlight Renewable Energy Ltd. (ENLT) projects a 41.67% EPS decrease and recorded an -83.33% miss in Q2 2025, highlighting potential operational challenges.

Valuation metrics reveal several companies, including Tencent Music (TME), GlobalFoundries (GFS), and CorMedix (CRMD), possess 2025 P/E ratios that imply higher earnings growth compared to their respective industry averages. This suggests either premium market valuation for anticipated outperformance or a favorable growth outlook relative to peers.

Companies like GlobalFoundries (GFS), Loar Holdings (LOAR), and ICL Group (ICL) have consistently beaten analyst expectations over the past year, despite varied current EPS growth forecasts. This track record could indicate conservative guidance or strong operational execution, warranting closer examination of their upcoming reports.

Key Decisions for Investors

• Focus on companies exhibiting strong forecasted EPS growth and favorable P/E implications, such as CorMedix (CRMD), On Holding (ONON), and IHS Holding (IHS), as these may signal significant operational momentum.
• Exercise caution with firms like Legend Biotech (LEGN) and Enlight Renewable Energy (ENLT) due to negative or substantially decreased EPS forecasts and recent misses, which could indicate underlying business challenges.
• Evaluate companies with a consistent history of beating expectations, including GlobalFoundries (GFS), Loar Holdings (LOAR), and ICL Group (ICL), as this pattern might suggest conservative guidance or robust execution, potentially leading to positive surprises.